Estimates of the global burden of non-Hodgkin lymphoma attributable to HIV: a population attributable modeling studyResearch in context

Summary: Background: Human immunodeficiency virus (HIV) significantly increases the risk of non-Hodgkin lymphoma (NHL) development, yet the population-level impact on NHL burden is unquantified. We aim to quantify this association and estimate the global burden of HIV-associated NHL. Methods: In th...

Full description

Bibliographic Details
Main Authors: Yan Chen, Jianhui Zhao, Ping Sun, Mengli Cheng, Yiquan Xiong, Zhaochen Sun, Yixuan Zhang, Kangning Li, Yunli Ye, Ping Shuai, Hairong Huang, Xue Li, Yuping Liu, Zhengwei Wan
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:EClinicalMedicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2589537023005473
_version_ 1797347072954859520
author Yan Chen
Jianhui Zhao
Ping Sun
Mengli Cheng
Yiquan Xiong
Zhaochen Sun
Yixuan Zhang
Kangning Li
Yunli Ye
Ping Shuai
Hairong Huang
Xue Li
Yuping Liu
Zhengwei Wan
author_facet Yan Chen
Jianhui Zhao
Ping Sun
Mengli Cheng
Yiquan Xiong
Zhaochen Sun
Yixuan Zhang
Kangning Li
Yunli Ye
Ping Shuai
Hairong Huang
Xue Li
Yuping Liu
Zhengwei Wan
author_sort Yan Chen
collection DOAJ
description Summary: Background: Human immunodeficiency virus (HIV) significantly increases the risk of non-Hodgkin lymphoma (NHL) development, yet the population-level impact on NHL burden is unquantified. We aim to quantify this association and estimate the global burden of HIV-associated NHL. Methods: In this meta-analysis, we searched five databases (PubMed, EMBASE, Cochrane Library, Web of Science, Scopus) from database inception up to September 13, 2023, identifying cohort, case–control, or cross-sectional studies with an effective control group to assess NHL risk among individuals with HIV infection, with two authors extracting summary data from reports. Global and regional HIV-associated population attributable fraction (PAF) and NHL disease burden were calculated based on the pooled risk ratio (RR). HIV prevalence and NHL incidence were obtained from the Joint United Nations Programme on HIV/AIDS (UNAIDS) and Global Burden of Diseases, Injuries, and Risk Factors Study 2019. Trends in NHL incidence due to HIV were assessed using age-standardised incidence rate (ASIR) and estimated annual percentage change (EAPC). This study was registered with PROSPERO (CRD42023404150). Findings: Out of 14,929 literature sources, 39 articles met our inclusion criteria. The risk of NHL was significantly increased in the population living with HIV (pooled RR 23.51, 95% CI 17.62–31.37; I2 = 100%, p < 0.0001), without publication bias. Globally, 6.92% (95% CI 2.18%–11.57%) of NHL new cases in 2019 were attributable to HIV infection (30,503, 95% CI 9585–52,209), which marked a more than three-fold increase from 1990 (8340, 95% CI 3346–13,799). The UNAIDS region of Eastern and Southern Africa was the highest affected region, with 44.46% (95% CI 19.62%–58.57%) of NHL new cases attributed to HIV infection. The Eastern Europe and Central Asia region experienced the highest increase in ASIR of NHL due to HIV in the past thirty years, wherein the EAPC was 8.74% (95% CI 7.66%–9.84%), from 2010 to 2019. Interpretation: People with HIV infection face a significantly increased risk of NHL. Targeted prevention and control policies are especially crucial for countries in Eastern and Southern Africa, Eastern Europe and Central Asia, to achieve the UNAIDS's ‘90-90-90’ Fast-Track targets. Limited studies across diverse regions and heterogeneity between research have hindered precise estimations for specific periods and regions. Funding: Sichuan Provincial People’s Hospital, Chengdu, China; Health Care for Cadres of Sichuan Province, Chengdu, China; Science and Technology Department of Sichuan Province, Chengdu, China.
first_indexed 2024-03-08T11:42:27Z
format Article
id doaj.art-6ce8c0af6a364fc8bd126e6c8cedcc14
institution Directory Open Access Journal
issn 2589-5370
language English
last_indexed 2024-03-08T11:42:27Z
publishDate 2024-01-01
publisher Elsevier
record_format Article
series EClinicalMedicine
spelling doaj.art-6ce8c0af6a364fc8bd126e6c8cedcc142024-01-25T05:23:31ZengElsevierEClinicalMedicine2589-53702024-01-0167102370Estimates of the global burden of non-Hodgkin lymphoma attributable to HIV: a population attributable modeling studyResearch in contextYan Chen0Jianhui Zhao1Ping Sun2Mengli Cheng3Yiquan Xiong4Zhaochen Sun5Yixuan Zhang6Kangning Li7Yunli Ye8Ping Shuai9Hairong Huang10Xue Li11Yuping Liu12Zhengwei Wan13Department of Health Management Centre &amp; Institute of Health Management, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China; School of Public Health, Southwest Medical University, Luzhou, ChinaDepartment of School of Public Health, Epidemiology and Biostatistics, Zhejiang University School of Medicine, Hangzhou, ChinaDepartment of Health Management Centre &amp; Institute of Health Management, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, ChinaNational Clinical Laboratory on Tuberculosis, Beijing Key Laboratory of Drug-Resistant Tuberculosis, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumour Institute, Beijing, ChinaChinese Evidence-based Medicine Centre, West China Hospital, Sichuan University, Chengdu, ChinaDepartment of Health Management Centre &amp; Institute of Health Management, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China; School of Public Health, Southwest Medical University, Luzhou, ChinaDepartment of School of Public Health, Epidemiology and Biostatistics, Zhejiang University School of Medicine, Hangzhou, ChinaDepartment of School of Public Health, Epidemiology and Biostatistics, Zhejiang University School of Medicine, Hangzhou, ChinaSchool of Public Health, Southwest Medical University, Luzhou, ChinaDepartment of Health Management Centre &amp; Institute of Health Management, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, ChinaNational Clinical Laboratory on Tuberculosis, Beijing Key Laboratory of Drug-Resistant Tuberculosis, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumour Institute, Beijing, ChinaDepartment of School of Public Health, Epidemiology and Biostatistics, Zhejiang University School of Medicine, Hangzhou, China; Corresponding author. Zhejiang University School of Medicine, 866 YuhangTang Rd, Xihu Dist., Hangzhou, 310058, China.Department of Health Management Centre &amp; Institute of Health Management, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China; Corresponding author. No. 32 West Second Section, First Ring Rd., Qingyang Dist., Chengdu, 610000, China.Department of Health Management Centre &amp; Institute of Health Management, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China; Corresponding author. No. 32 West Second Section, First Ring Rd., Qingyang Dist., Chengdu, 610000, China.Summary: Background: Human immunodeficiency virus (HIV) significantly increases the risk of non-Hodgkin lymphoma (NHL) development, yet the population-level impact on NHL burden is unquantified. We aim to quantify this association and estimate the global burden of HIV-associated NHL. Methods: In this meta-analysis, we searched five databases (PubMed, EMBASE, Cochrane Library, Web of Science, Scopus) from database inception up to September 13, 2023, identifying cohort, case–control, or cross-sectional studies with an effective control group to assess NHL risk among individuals with HIV infection, with two authors extracting summary data from reports. Global and regional HIV-associated population attributable fraction (PAF) and NHL disease burden were calculated based on the pooled risk ratio (RR). HIV prevalence and NHL incidence were obtained from the Joint United Nations Programme on HIV/AIDS (UNAIDS) and Global Burden of Diseases, Injuries, and Risk Factors Study 2019. Trends in NHL incidence due to HIV were assessed using age-standardised incidence rate (ASIR) and estimated annual percentage change (EAPC). This study was registered with PROSPERO (CRD42023404150). Findings: Out of 14,929 literature sources, 39 articles met our inclusion criteria. The risk of NHL was significantly increased in the population living with HIV (pooled RR 23.51, 95% CI 17.62–31.37; I2 = 100%, p < 0.0001), without publication bias. Globally, 6.92% (95% CI 2.18%–11.57%) of NHL new cases in 2019 were attributable to HIV infection (30,503, 95% CI 9585–52,209), which marked a more than three-fold increase from 1990 (8340, 95% CI 3346–13,799). The UNAIDS region of Eastern and Southern Africa was the highest affected region, with 44.46% (95% CI 19.62%–58.57%) of NHL new cases attributed to HIV infection. The Eastern Europe and Central Asia region experienced the highest increase in ASIR of NHL due to HIV in the past thirty years, wherein the EAPC was 8.74% (95% CI 7.66%–9.84%), from 2010 to 2019. Interpretation: People with HIV infection face a significantly increased risk of NHL. Targeted prevention and control policies are especially crucial for countries in Eastern and Southern Africa, Eastern Europe and Central Asia, to achieve the UNAIDS's ‘90-90-90’ Fast-Track targets. Limited studies across diverse regions and heterogeneity between research have hindered precise estimations for specific periods and regions. Funding: Sichuan Provincial People’s Hospital, Chengdu, China; Health Care for Cadres of Sichuan Province, Chengdu, China; Science and Technology Department of Sichuan Province, Chengdu, China.http://www.sciencedirect.com/science/article/pii/S2589537023005473HIVNon-Hodgkin lymphomaRisk ratioPopulation attributable fractionGlobal burden
spellingShingle Yan Chen
Jianhui Zhao
Ping Sun
Mengli Cheng
Yiquan Xiong
Zhaochen Sun
Yixuan Zhang
Kangning Li
Yunli Ye
Ping Shuai
Hairong Huang
Xue Li
Yuping Liu
Zhengwei Wan
Estimates of the global burden of non-Hodgkin lymphoma attributable to HIV: a population attributable modeling studyResearch in context
EClinicalMedicine
HIV
Non-Hodgkin lymphoma
Risk ratio
Population attributable fraction
Global burden
title Estimates of the global burden of non-Hodgkin lymphoma attributable to HIV: a population attributable modeling studyResearch in context
title_full Estimates of the global burden of non-Hodgkin lymphoma attributable to HIV: a population attributable modeling studyResearch in context
title_fullStr Estimates of the global burden of non-Hodgkin lymphoma attributable to HIV: a population attributable modeling studyResearch in context
title_full_unstemmed Estimates of the global burden of non-Hodgkin lymphoma attributable to HIV: a population attributable modeling studyResearch in context
title_short Estimates of the global burden of non-Hodgkin lymphoma attributable to HIV: a population attributable modeling studyResearch in context
title_sort estimates of the global burden of non hodgkin lymphoma attributable to hiv a population attributable modeling studyresearch in context
topic HIV
Non-Hodgkin lymphoma
Risk ratio
Population attributable fraction
Global burden
url http://www.sciencedirect.com/science/article/pii/S2589537023005473
work_keys_str_mv AT yanchen estimatesoftheglobalburdenofnonhodgkinlymphomaattributabletohivapopulationattributablemodelingstudyresearchincontext
AT jianhuizhao estimatesoftheglobalburdenofnonhodgkinlymphomaattributabletohivapopulationattributablemodelingstudyresearchincontext
AT pingsun estimatesoftheglobalburdenofnonhodgkinlymphomaattributabletohivapopulationattributablemodelingstudyresearchincontext
AT menglicheng estimatesoftheglobalburdenofnonhodgkinlymphomaattributabletohivapopulationattributablemodelingstudyresearchincontext
AT yiquanxiong estimatesoftheglobalburdenofnonhodgkinlymphomaattributabletohivapopulationattributablemodelingstudyresearchincontext
AT zhaochensun estimatesoftheglobalburdenofnonhodgkinlymphomaattributabletohivapopulationattributablemodelingstudyresearchincontext
AT yixuanzhang estimatesoftheglobalburdenofnonhodgkinlymphomaattributabletohivapopulationattributablemodelingstudyresearchincontext
AT kangningli estimatesoftheglobalburdenofnonhodgkinlymphomaattributabletohivapopulationattributablemodelingstudyresearchincontext
AT yunliye estimatesoftheglobalburdenofnonhodgkinlymphomaattributabletohivapopulationattributablemodelingstudyresearchincontext
AT pingshuai estimatesoftheglobalburdenofnonhodgkinlymphomaattributabletohivapopulationattributablemodelingstudyresearchincontext
AT haironghuang estimatesoftheglobalburdenofnonhodgkinlymphomaattributabletohivapopulationattributablemodelingstudyresearchincontext
AT xueli estimatesoftheglobalburdenofnonhodgkinlymphomaattributabletohivapopulationattributablemodelingstudyresearchincontext
AT yupingliu estimatesoftheglobalburdenofnonhodgkinlymphomaattributabletohivapopulationattributablemodelingstudyresearchincontext
AT zhengweiwan estimatesoftheglobalburdenofnonhodgkinlymphomaattributabletohivapopulationattributablemodelingstudyresearchincontext